Focal to bilateral tonic-clonic seizures are associated with widespread network abnormality in temporal lobe epilepsy

Nishant Sinha1,2, Natalie Peternell2, Gabrielle M Schroeder2

  • 1Faculty of Medical Sciences, Translational and Clinical Research Institute, Newcastle University, Newcastle Upon Tyne, UK.

Epilepsia
|January 21, 2021
PubMed
Abstract

Insights

Patients with temporal lobe epilepsy (TLE) and focal to bilateral tonic-clonic seizures (FBTCS) show more widespread brain network alterations. These widespread changes in structural networks may explain the greater seizure spread in FBTCS patients.

Area of Science:

  • Neuroscience
  • Medical Imaging
  • Epilepsy Research

Background:

  • Temporal lobe epilepsy (TLE) is a common neurological disorder.
  • Focal to bilateral tonic-clonic seizures (FBTCS) represent a severe manifestation of TLE.
  • Understanding structural network differences in TLE with and without FBTCS is crucial for targeted therapies.

Purpose of the Study:

  • To investigate and compare whole-brain structural network alterations in TLE patients with and without FBTCS.
  • To determine if the extent and localization of network abnormalities differ between TLE patients experiencing FBTCS and those who do not.

Main Methods:

  • Utilized diffusion-weighted magnetic resonance imaging (DW-MRI) to construct whole-brain structural networks in 83 drug-resistant TLE patients and 29 healthy controls.
  • Dichotomized TLE patients into FBTCS-positive (FBTCS+) and FBTCS-negative (FBTCS-) groups for comparative analysis against controls.
  • Quantified network alterations by measuring fractional anisotropy and mean diffusivity, and assessed subject-specific abnormalities in brain regions.

Main Results:

  • Both FBTCS+ and FBTCS- groups exhibited altered subnetworks compared to controls, indicated by reduced fractional anisotropy and increased mean diffusivity.
  • FBTCS+ patients displayed significantly more widespread network alterations (441 connections) than FBTCS- patients (21 connections).
  • Abnormalities were more extensive and globally distributed in FBTCS+ patients, while FBTCS- patients showed localized changes primarily in temporal and frontal areas.

Conclusions:

  • Whole-brain structural networks are significantly more altered and widespread in TLE patients with FBTCS.
  • These pronounced network abnormalities may represent the structural basis or consequence of increased seizure propagation in FBTCS.
  • Findings highlight distinct network profiles in TLE based on seizure manifestation, informing potential diagnostic and therapeutic strategies.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.0K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
896
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.3K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
955
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
875
Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
696